Lysophosphatidylinositol signalling and metabolic diseases

Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and respon...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmad Arifin, Syamsul, Falasca, Marco
Format: Article
Language:English
English
English
Published: 2016
Subjects:
Online Access:http://irep.iium.edu.my/52928/1/metabolites-06-00006.pdf
http://irep.iium.edu.my/52928/7/52928_Lysophosphatidylinositol_WOS.pdf
http://irep.iium.edu.my/52928/13/52928_Lysophosphatidylinositol%20signalling_scopus.pdf
http://irep.iium.edu.my/52928/
http://www.mdpi.com/2218-1989/6/1/6
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Islam Antarabangsa Malaysia
Language: English
English
English
id my.iium.irep.52928
record_format dspace
spelling my.iium.irep.529282017-10-20T07:17:03Z http://irep.iium.edu.my/52928/ Lysophosphatidylinositol signalling and metabolic diseases Ahmad Arifin, Syamsul Falasca, Marco QP Physiology RM283 Endocrinotheraphy Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and response to the environment, leading to the development of a metabolic disease. Metabolic syndrome, a cluster of several metabolic risk factors such as abdominal obesity, insulin resistance, high cholesterol and high blood pressure, and atherogenic dyslipidaemia, is increasingly common in modern society. Metabolic syndrome, as well as other diseases, such as diabetes, obesity, hyperlipidaemia and hypertension, are associated with abnormal lipid metabolism. Cellular lipids are the major component of cell membranes; they represent also a valuable source of energy and therefore play a crucial role for both cellular and physiological energy homeostasis. In this review, we will focus on the physiological and pathophysiological roles of the lysophospholipid mediator lysophosphatidylinositol (LPI) and its receptor G-protein coupled receptor 55 (GPR55) in metabolic diseases. LPI is a bioactive lipid generated by phospholipase A (PLA) family of lipases which is believed to play an important role in several diseases. Indeed LPI can affect various functions such as cell growth, differentiation and motility in a number of cell-types. Recently published data suggest that LPI plays an important role in different physiological and pathological contexts, including a role in metabolism and glucose homeostasis. 2016-01-01 Article REM application/pdf en http://irep.iium.edu.my/52928/1/metabolites-06-00006.pdf application/pdf en http://irep.iium.edu.my/52928/7/52928_Lysophosphatidylinositol_WOS.pdf application/pdf en http://irep.iium.edu.my/52928/13/52928_Lysophosphatidylinositol%20signalling_scopus.pdf Ahmad Arifin, Syamsul and Falasca, Marco (2016) Lysophosphatidylinositol signalling and metabolic diseases. Metabolites, 6 (1). pp. 1-11. ISSN 2218-1989 http://www.mdpi.com/2218-1989/6/1/6 10.3390/metabo6010006
institution Universiti Islam Antarabangsa Malaysia
building IIUM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
url_provider http://irep.iium.edu.my/
language English
English
English
topic QP Physiology
RM283 Endocrinotheraphy
spellingShingle QP Physiology
RM283 Endocrinotheraphy
Ahmad Arifin, Syamsul
Falasca, Marco
Lysophosphatidylinositol signalling and metabolic diseases
description Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and response to the environment, leading to the development of a metabolic disease. Metabolic syndrome, a cluster of several metabolic risk factors such as abdominal obesity, insulin resistance, high cholesterol and high blood pressure, and atherogenic dyslipidaemia, is increasingly common in modern society. Metabolic syndrome, as well as other diseases, such as diabetes, obesity, hyperlipidaemia and hypertension, are associated with abnormal lipid metabolism. Cellular lipids are the major component of cell membranes; they represent also a valuable source of energy and therefore play a crucial role for both cellular and physiological energy homeostasis. In this review, we will focus on the physiological and pathophysiological roles of the lysophospholipid mediator lysophosphatidylinositol (LPI) and its receptor G-protein coupled receptor 55 (GPR55) in metabolic diseases. LPI is a bioactive lipid generated by phospholipase A (PLA) family of lipases which is believed to play an important role in several diseases. Indeed LPI can affect various functions such as cell growth, differentiation and motility in a number of cell-types. Recently published data suggest that LPI plays an important role in different physiological and pathological contexts, including a role in metabolism and glucose homeostasis.
format Article
author Ahmad Arifin, Syamsul
Falasca, Marco
author_facet Ahmad Arifin, Syamsul
Falasca, Marco
author_sort Ahmad Arifin, Syamsul
title Lysophosphatidylinositol signalling and metabolic diseases
title_short Lysophosphatidylinositol signalling and metabolic diseases
title_full Lysophosphatidylinositol signalling and metabolic diseases
title_fullStr Lysophosphatidylinositol signalling and metabolic diseases
title_full_unstemmed Lysophosphatidylinositol signalling and metabolic diseases
title_sort lysophosphatidylinositol signalling and metabolic diseases
publishDate 2016
url http://irep.iium.edu.my/52928/1/metabolites-06-00006.pdf
http://irep.iium.edu.my/52928/7/52928_Lysophosphatidylinositol_WOS.pdf
http://irep.iium.edu.my/52928/13/52928_Lysophosphatidylinositol%20signalling_scopus.pdf
http://irep.iium.edu.my/52928/
http://www.mdpi.com/2218-1989/6/1/6
_version_ 1643614256392830976